Immix Biopharma, Inc. IMMX Grants Receivable Based On Achievement Of Milestones
Grants Receivable Based On Achievement Of Milestones at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept IMMX:GrantsReceivableBasedOnAchievementOfMilestones.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s grants receivable based on achievement of milestones.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s grants receivable based on achievement of milestones?
- Immix Biopharma, Inc. (IMMX) reported grants receivable based on achievement of milestones of $1.8M in Q1 2026.
- What does grants receivable based on achievement of milestones mean?
- This reflects grant funding that is contingent upon the successful completion of specific clinical or technical milestones. It provides insight into the company's progress toward achieving key research objectives that trigger external financial support. This metric is a proxy for operational success in meeting pre-defined development goals.